Skip to main content

Nonhospitalized Patients With Post-COVID Condition Tolerate Exercise

Medically reviewed by Carmen Pope, BPharm. Last updated on April 5, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, April 5, 2024 -- Nonhospitalized patients with post-COVID condition (PCC) tolerate exercise, with preserved cardiovascular function, but have lower aerobic capacity, according to a study published online April 4 in JAMA Network Open.

Andrea Tryfonos, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues conducted a randomized, crossover trial involving nonhospitalized patients without concomitant diseases and with persistent (at least three months) symptoms after severe acute respiratory syndrome coronavirus 2 infection. Postexertional symptoms were compared in patients with PCC versus control participants (31 in each group).

The researchers found that at all time points, patients with PCC reported more symptoms than controls. No difference was seen between the groups in worsening of fatigue in response to the different exercises (high-intensity interval training [HIIT], moderate-intensity continuous training [MICT], and strength training). Greater exacerbation of muscle pain after HIIT and more concentration difficulties after MICT were seen for patients with PCC compared with controls. Patients with PCC showed preserved lung and heart function at baseline compared with controls, but had a 21 percent lower peak volume of oxygen consumption and less isometric knee extension muscle strength. PCC patients spent 43 percent less time on moderate-to-vigorous physical activity.

"Nonhospitalized patients with PCC generally tolerated all exercise types without reporting significant symptom exacerbation, performance reductions, or exacerbated inflammation after 48 hours," the authors write. "Given that exercise was generally well tolerated, guidelines cautioning against exercise in similar populations may need to be revised."

Several authors disclosed ties to the biopharmaceutical industry; one author disclosed a patent for an airway device.

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Elevated BMI Linked to Postacute Sequelae of SARS-CoV-2 in Children

WEDNESDAY, Oct. 30, 2024 -- For children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, elevated body mass index (BMI) is associated with an...

Cognitive Therapy, Modafinil, Combo All Beneficial for Multiple Sclerosis Fatigue

FRIDAY, Oct. 25, 2024 -- Cognitive behavioral therapy (CBT), modafinil, and their combination are equally beneficial for multiple sclerosis fatigue, according to a study published...

ASA: Risk for Postoperative Delirium Increased With Poor and Worsening Sleep

FRIDAY, Oct. 25, 2024 -- Inadequate sleep and worsening sleep trajectory are associated with postoperative delirium among adults undergoing noncardiac surgery under general...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.